Vanda Pharmaceuticals | VNDA - Pe Kurs-Gewinn

Aktienkurs
7.21
Täglich Wechseln
0.39 5.72%
Monatlich
-16.16%
Jährlich
51.15%
Q1 Prognose
6.91




Pe Veränderung Datum
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0.68 2025-09
Akebia Therapeutics 1.63K 1.6K 2025-12
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Anika Therapeutics 47.54 27.2 2024-06
AstraZeneca 27.29 5.8 2025-12
Bristol-Myers Squibb 9.28 1.04 2025-12
Eli Lilly 40.21 9.66 2025-12
Esperion Therapeutics 129.79 129 2024-12
Halozyme Therapeutics 23.16 7.7 2025-12
J&J 23.62 0.86 2025-12
Lexicon Pharmaceuticals 12.44 4.73 2021-06
Ligand Pharmaceuticals 60.65 17.62 2025-09
Merck 13.92 5.08 2025-12
Moderna 27.22 14.51 2023-06
Novartis 17.79 1.74 2025-12
Pfizer 14.48 5.18 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Sanofi 11.99 1.58 2025-12
Takeda 235.05 184.95 2025-12
Teva Pharmaceutical Industries 10.11 1.04 2025-12
Vanda Pharmaceuticals 16.79 7.07 2023-06
Veracyte 45.3 5.4 2025-12